Patent Assignment
Reel/Frame 029030/0001
Change of Name
Recorded: 2012-09-26
Pages: 89
Assignor
EDT PHARMA HOLDINGS LIMITED
Executed: 2011-09-14
Assignee
ALKERMES PHARMA IRELAND LIMITED
CONNAUGHT ROAD, 1 BURLINGTON ROAD, DUBLIN 4,, IRELAND
Covered Properties
(30)
Method of Grinding Pharmaceutical Substances
Patent:
5,518,187 →
Application:
08/180,827 →
Iodinated Aroyloxy Ketones
Patent:
5,488,133 →
Application:
08/209,181 →
Nanoparticulate Diagnostic Diatrizoxy Ester X-Ray Contrast Agents for Blood Pool and Lymphatic System Imaging
Patent:
5,525,328 →
Application:
08/265,550 →
Butylene Oxide-Ethylene Oxide Block Copolymer Surfactants as Stabilizer Coatings for Nanoparticle Compositions
Patent:
5,587,143 →
Application:
08/267,082 →
Formulations of Oral Gastrointestinal Therapeutic Agents in Combination with Pharmaceutically Acceptable Clays
Patent:
5,585,108 →
Application:
08/366,518 →
Formulations of Oral Gastrointestinal Diagnostic X-Ray Contrast Agents and Oral Gastrointestinal Therapeutic Agents
Patent:
5,628,981 →
Application:
08/366,841 →
Microprecipitation of Nanoparticulate Pharmaceutical Agents
Patent:
5,560,932 →
Application:
08/370,955 →
Sulfated Nonionic Block Copolymer Surfactants as Stabilizer Coatings for Nanoparticle Compositions
Patent:
5,569,448 →
Application:
08/378,022 →
Formulations of Compounds as Nanoparticulate Dispersions in Digestible Oils or Fatty Acids
Patent:
5,571,536 →
Application:
08/384,057 →
Isolation of Ultra Small Particles
Patent:
5,503,723 →
Application:
08/385,531 →
Nanoparticulate Nsaid Compositions
Patent:
5,518,738 →
Application:
08/385,614 →
Novel Barium Salt Formulations Stabilized by Non-Ionic and Anionic Stabilizers
Patent:
5,593,657 →
Application:
08/386,027 →
Method of Preparing Stable Drug Nanoparticles
Patent:
5,534,270 →
Application:
08/386,028 →
Nanoparticulate Diagnostic Dimers as X-Ray Contrast Agents for Blood Pool and Lymphatic System Imaging
Patent:
5,500,204 →
Application:
08/386,788 →
Milled Naproxen with Hydroxypropyl Cellulose as a Dispersion Stabilizer
Patent:
5,591,456 →
Application:
08/386,790 →
Redispersible Nanoparticulate Film Matrices with Protective Overcoats
Patent:
5,573,783 →
Application:
08/387,651 →
Formulations of Compounds as Nanoparticulate Dispersions in Digestible Oils or Fatty Acids
Patent:
5,560,931 →
Application:
08/388,088 →
Process of Preparing Therapeutic Compositions Containing Nanoparticles
Patent:
5,510,118 →
Application:
08/388,092 →
Process of Preparing X-Ray Contrast Compositions Containing Nanoparticles
Patent:
5,543,133 →
Application:
08/388,099 →
Site-Specific Adhesion Within the Gi Tract Using Nanoparticles Stabilized by High Molecular Weight, Linear Poly (Ethylene Oxide) Polymers
Patent:
5,580,579 →
Application:
08/388,878 →
Polyalkylene Block Copolymers as Surface Modifiers for Nanoparticles
Patent:
5,565,188 →
Application:
08/393,972 →
Nanoparticulate Diagnostic Mixed Carboxylic Anhydrides as X-Ray Contrast Agents for Blood Pool and Lymphatic System Imaging
Patent:
5,573,749 →
Application:
08/401,397 →
Nanoparticulate Diagnostic Mixed Carbamic Anhydrides as X-Ray Contrast Agents for Blood Pool and Lymphatic System Imaging
Patent:
5,472,683 →
Application:
08/401,570 →
Nanoparticulate Iodipamide Derivatives for Use as X-Ray Contrast Agents
Patent:
5,521,218 →
Application:
08/440,794 →
Sugar Base Surfactant for Nanocrystals
Patent:
5,622,938 →
Application:
08/444,796 →
3 5-Bis Alkanoyl Amino-2 4 6-Triiodobenzyl Esters
Patent:
5,603,916 →
Application:
08/447,132 →
Diagnostic Imaging X-Ray Contrast Agents
Patent:
5,573,750 →
Application:
08/447,133 →
Nanoparticulate Diagnostic Mixed Carbonic Anhydrides as X-Ray Contrast Agents for Blood Pool and Lymphatic System Imaging
Patent:
5,643,552 →
Application:
08/524,145 →
Pharmaceutical Compositions Containing Polyalkylene Block Copolymers Which Gel at Physiological Temperature
Patent:
5,705,194 →
Application:
08/727,863 →
Formulations for Therapeutic Agents Absorbed Through Mucous Membranes
Related Assignments
(6)
Other recorded transfers of the patents in this record — the chain of ownership.
Patent Security Agreement (First Lien)
Sep 29, 2011
From: ALKERMES, INC.; ALKERMES PHARMA IRELAND LIMITED; ALKERMES CONTROLLED THERAPEUTICS INC.
To: MORGAN STANLEY SENIOR FUNDING, INC.
Reel/Frame 026994/0186 →
Patent Security Agreement (Second Lien)
Sep 29, 2011
From: ALKERMES, INC.; ALKERMES PHARMA IRELAND LIMITED; ALKERMES CONTROLLED THERAPEUTICS INC.
To: MORGAN STANLEY SENIOR FUNDING, INC.
Reel/Frame 026994/0245 →
Asset Transfer Agreement
Sep 26, 2012
From: ELAN PHARMA INTERNATIONAL LIMITED
To: EDT PHARMA HOLDINGS LIMITED
Reel/Frame 029043/0479 →
Release by Secured Party (Second Lien)
Oct 12, 2012
From: MORGAN STANLEY SENIOR FUNDING, INC.
To: ALKERMES, INC.; ALKERMES PHARMA IRELAND LIMITED; ALKERMES CONTROLLED THERAPEUTICS INC.
Reel/Frame 029116/0379 →
Release of Security Interest in Patents
Nov 14, 2012
From: WELLS FARGO BANK, NATIONAL ASSOCIATION
To: ARLON, INC. (N/K/A ARLON LLC)
Reel/Frame 029300/0494 →
Release of Patent Security Agreement (First Lien)
Dec 24, 2024
From: MORGAN STANLEY SENIOR FUNDING, INC.
To: ALKERMES, INC.; ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 069771/0548 →